About Temple University Health System
Clinical Trials at Temple University Health System
During the past decade, Temple University Health System conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Temple University Health System" #1 sponsor was "CVRx, Inc." with 1 trials, followed by "Fox Chase Cancer Center" with 1 trials
sponsored, "Genfit" with 1 trials sponsored, "Temple University" with 1 trials sponsored and "University of Michigan"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Temple University Health System"
#1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "National Institute on Minority Health and Health Disparities (NIMHD)" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator, "Pulmonary Fibrosis Foundation" with 1 trials as a collaborator and "Temple University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Temple University Health System
According to Clinical.Site data, the most researched conditions in "Temple University Health System" are
"Conflict" (1 trials), "Decisional Conflict" (1 trials), "Hypertension" (1 trials), "Idiopathic Pulmonary Fibrosis (IPF)" (1 trials) and "Interstitial Lung Disease (ILD)" (1 trials). Many other conditions were trialed in "Temple University Health System" in a lesser frequency.
Clinical Trials Intervention Types at Temple University Health System
Most popular intervention types in "Temple University Health System" are "Behavioral" (1 trials), "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cohort Observational study" (1 trials), "Elafibranor" (1 trials), "Placebo" (1 trials), "Rheos® Baroreflex Hypertension System" (1 trials) and "mychoice" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Temple University Health System
The vast majority of trials in "Temple University Health System" are
5 trials for "All" genders.
Clinical Trials Status at Temple University Health System
Currently, there are NaN active trials in "Temple University Health System".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Temple University Health System,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Temple University Health System, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".
Departments of Temple University Health System
Temple University Health System has several departments that took part in Clinical trials: "MDA/ALS Center of Hope" - 10 trials, "Temple University Cancer Center" - 8 trials, "Temple University Hospital Department of OB/GYN" - 2 trials